- Home
- ONEG vs FGEN Comparison
ONEG vs FGEN Comparison
Compare ONEG & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- FGEN
- Stock Information
- Founded
- ONEG 2021
- FGEN 1993
- Country
- ONEG Hong Kong
- FGEN United States
- Employees
- ONEG N/A
- FGEN N/A
- Industry
- ONEG Homebuilding
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- FGEN Health Care
- Exchange
- ONEG Nasdaq
- FGEN Nasdaq
- Market Cap
- ONEG 41.4M
- FGEN 34.5M
- IPO Year
- ONEG 2024
- FGEN 2014
- Fundamental
- Price
- ONEG $2.36
- FGEN $0.71
- Analyst Decision
- ONEG
- FGEN Strong Buy
- Analyst Count
- ONEG 0
- FGEN 1
- Target Price
- ONEG N/A
- FGEN $10.00
- AVG Volume (30 Days)
- ONEG 18.0K
- FGEN 7.2M
- Earning Date
- ONEG 01-01-0001
- FGEN 03-04-2025
- Dividend Yield
- ONEG N/A
- FGEN N/A
- EPS Growth
- ONEG N/A
- FGEN N/A
- EPS
- ONEG 0.16
- FGEN N/A
- Revenue
- ONEG $63,463,000.00
- FGEN $180,015,000.00
- Revenue This Year
- ONEG N/A
- FGEN $21.91
- Revenue Next Year
- ONEG N/A
- FGEN N/A
- P/E Ratio
- ONEG $15.01
- FGEN N/A
- Revenue Growth
- ONEG 16.46
- FGEN 16.15
- 52 Week Low
- ONEG $1.96
- FGEN $0.18
- 52 Week High
- ONEG $4.05
- FGEN $2.80
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- FGEN 65.95
- Support Level
- ONEG N/A
- FGEN $0.54
- Resistance Level
- ONEG N/A
- FGEN $0.88
- Average True Range (ATR)
- ONEG 0.00
- FGEN 0.07
- MACD
- ONEG 0.00
- FGEN 0.02
- Stochastic Oscillator
- ONEG 0.00
- FGEN 59.79
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.